title: Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
authors.forename: Igor
authors.initials: I
authors.lastname: Galynker
authors.forename: Asim
authors.initials: A
authors.lastname: Khan
authors.forename: Yuli
authors.initials: Y
authors.lastname: Grebchenko
authors.forename: Aleksey
authors.initials: A
authors.lastname: Ten
authors.forename: Liliya
authors.initials: L
authors.lastname: Malaya
authors.forename: Philip
authors.initials: P
authors.lastname: Yanowitch
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Cohen
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D018967:Risperidone